UB Paderborn / Katalog / Suche / in CDI

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial

The lancet oncology, 2016-05, Vol.17 (5), p.651-662

2016

Link zum Volltext

Verfügbarkeit prüfen

Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses

Cancer research (Chicago, Ill.), 2013-02, Vol.73 (3), p.1128-1141

2013

Link zum Volltext

Verfügbarkeit prüfen

Regional Lymphadenectomy Is Indicated in the Surgical Treatment of Pancreatic Neuroendocrine Tumors (PNETs)

Annals of surgery, 2014-02, Vol.259 (2), p.197-203

2014

Link zum Volltext

Verfügbarkeit prüfen

Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance

Nature communications, 2018-03, Vol.9 (1), p.1250-19, Article 1250

2018

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis

Clinical cancer research, 2013-07, Vol.19 (13), p.3404-3415

2013

Link zum Volltext

Verfügbarkeit prüfen

Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement

Annals of surgical oncology, 2009-07, Vol.16 (7), p.1727-1733

2009

Link zum Volltext

Verfügbarkeit prüfen

Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer

Clinical cancer research, 2020-01, Vol.26 (1), p.82-92

2020

Link zum Volltext

Verfügbarkeit prüfen

Long-term results of resection of adenocarcinoma of the body and tail of the pancreas using radical antegrade modular pancreatosplenectomy procedure

Journal of the American College of Surgeons, 2012-01, Vol.214 (1), p.46

2012

Link zum Volltext

Verfügbarkeit prüfen

Targeting tumor-infiltrating macrophages to combat cancer

Immunotherapy, 2013-10, Vol.5 (10), p.1075

2013

Link zum Volltext

Verfügbarkeit prüfen

Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer

Cancer Immunology, Immunotherapy, 2014-05, Vol.63 (5), p.513-528

2014

Link zum Volltext

Verfügbarkeit prüfen

Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth

Cancer Immunology, Immunotherapy, 2012-09, Vol.61 (9), p.1373-1385

2012

Link zum Volltext

Verfügbarkeit prüfen

Recruitment of CCR2+ tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer

Oncoimmunology, 2018-09, Vol.7 (9), p.e1470729-e1470729

2018

Link zum Volltext

Verfügbarkeit prüfen

Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment

Cell reports (Cambridge), 2019-10, Vol.29 (2), p.406-421.e5

2019

Link zum Volltext

Verfügbarkeit prüfen

Ki-67 predicts disease recurrence and poor prognosis in pancreatic neuroendocrine neoplasms

Surgery, 2012-07, Vol.152 (1), p.107-113

2012

Link zum Volltext

Verfügbarkeit prüfen

Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer

The Journal of immunology (1950), 2010-10, Vol.185 (7), p.4063-4071

2010

Link zum Volltext

Verfügbarkeit prüfen

Radical antegrade modular pancreatosplenectomy procedure for adenocarcinoma of the body and tail of the pancreas: ability to obtain negative tangential margins

Journal of the American College of Surgeons, 2007-02, Vol.204 (2), p.244

2007

Link zum Volltext

Verfügbarkeit prüfen

RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells

PloS one, 2011-02, Vol.6 (2), p.e16958

2011

Link zum Volltext

Verfügbarkeit prüfen

Immunologic Strategies in Pancreatic Cancer: Making Cold Tumors Hot

Journal of clinical oncology, 2022-08, Vol.40 (24), p.2789-2805

2022

Link zum Volltext

Verfügbarkeit prüfen

Severe nutritional risk predicts decreased long-term survival in geriatric patients undergoing pancreaticoduodenectomy for benign disease

Journal of the American College of Surgeons, 2014-12, Vol.219 (6), p.1149

2014

Link zum Volltext

Verfügbarkeit prüfen

Bile duct injuries in the era of laparoscopic cholecystectomies

The Surgical clinics of North America, 2010-08, Vol.90 (4), p.787

2010

Link zum Volltext

Verfügbarkeit prüfen

The Accordion Severity Grading System of Surgical Complications

Annals of surgery, 2009-08, Vol.250 (2), p.177-186

2009

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial

Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses

Regional Lymphadenectomy Is Indicated in the Surgical Treatment of Pancreatic Neuroendocrine Tumors (PNETs)

Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance

Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis

Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement

Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer

Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer

Long-term results of resection of adenocarcinoma of the body and tail of the pancreas using radical antegrade modular pancreatosplenectomy procedure

Targeting tumor-infiltrating macrophages to combat cancer

Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer

Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth

Recruitment of CCR2+ tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer

Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival

Interaction of Postoperative Morbidity and Receipt of Adjuvant Therapy on Long-Term Survival After Resection for Gastric Adenocarcinoma: Results From the U.S. Gastric Cancer Collaborative

Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment

Ki-67 predicts disease recurrence and poor prognosis in pancreatic neuroendocrine neoplasms

Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer

Radical antegrade modular pancreatosplenectomy procedure for adenocarcinoma of the body and tail of the pancreas: ability to obtain negative tangential margins

New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy

RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells

Immunologic Strategies in Pancreatic Cancer: Making Cold Tumors Hot

Severe nutritional risk predicts decreased long-term survival in geriatric patients undergoing pancreaticoduodenectomy for benign disease

Bile duct injuries in the era of laparoscopic cholecystectomies

The Accordion Severity Grading System of Surgical Complications

Suchergebnisse filtern